%0 Journal Article
%T Stem cells as therapy for cardiac disease — a review
%A Katarzyna Jezierska-WoŁżniak
%A Dorota Mystkowska
%A Anna Tutas
%A Marek Kajetan Jurkowski
%J Folia Histochemica et Cytobiologica
%D 2011
%I Polish Histochemical and Cytochemical Society
%R 10.5603/4139
%X Acute myocardial infarction (AMI) is one of the most significant causes of morbidity and mortality worldwide. Stem cells represent an enormous chance to rebuild damaged heart tissue. Correct definition of the cardiac progenitors is necessary to understand heart development, and would pave the way for the use of cardiac progenitors in the treatment of heart disease. Identifying, purifying and differentiating native cardiac progenitor cells are indispensable if we are to overcome congenital and adult cardiac diseases. To understand their functions, physiology and action, cells are tested in animal models, and then in clinical trials. But because clinical trials yield variable results, questions about proper cardiac stem cells remain unanswered. Transplanted stem cells release soluble factors, acting in a paracrine fashion, which contributes to cardiac regeneration. Cytokines and growth factors have cytoprotective and neovascularizing functions, and may activate resident cardiac stem cells. Understanding all these mechanisms is crucial to overcoming heart diseases. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 1, pp. 13¨C25)
%K cell therapy
%K stem cells
%K heart failure
%K paracrine signaling
%U http://czasopisma.viamedica.pl/fhc/article/view/4139